| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1995PNAS...92.9004B |
| P356 | DOI | 10.1073/PNAS.92.19.9004 |
| P932 | PMC publication ID | 41096 |
| P698 | PubMed publication ID | 7568061 |
| P5875 | ResearchGate publication ID | 15631179 |
| P2093 | author name string | Berger EA | |
| Broder CC | |||
| P2860 | cites work | Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase | Q27860943 |
| Complete nucleotide sequence of the AIDS virus, HTLV-III | Q28259080 | ||
| The Lipophilic Muramyl Peptide MTP-PE Is a Potent Inhibitor of HIV Replication in Macrophages | Q28323567 | ||
| Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone | Q29547734 | ||
| The role of mononuclear phagocytes in HTLV-III/LAV infection | Q29618676 | ||
| Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS. | Q30355613 | ||
| Human immunodeficiency virus type 1 tropism for human macrophages | Q35353139 | ||
| Proteinase-resistant factors in human erythrocyte membranes mediate CD4-dependent fusion with cells expressing human immunodeficiency virus type 1 envelope glycoproteins | Q35832208 | ||
| Spontaneous substitutions in the vicinity of the V3 analog affect cell tropism and pathogenicity of simian immunodeficiency virus | Q36632673 | ||
| The "V3" domain is a determinant of simian immunodeficiency virus cell tropism. | Q36634149 | ||
| Fusogenic mechanisms of enveloped-virus glycoproteins analyzed by a novel recombinant vaccinia virus-based assay quantitating cell fusion-dependent reporter gene activation. | Q36634800 | ||
| Infection of macrophages with lymphotropic human immunodeficiency virus type 1 can be arrested after viral DNA synthesis | Q36654734 | ||
| Phenotypic heterogeneity in a panel of infectious molecular human immunodeficiency virus type 1 clones derived from a single individual | Q36684257 | ||
| Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism | Q36685201 | ||
| Biological and immunological properties of human immunodeficiency virus type 1 envelope glycoprotein: analysis of proteins with truncations and deletions expressed by recombinant vaccinia viruses | Q36687749 | ||
| Regulated expression of foreign genes in vaccinia virus under the control of bacteriophage T7 RNA polymerase and the Escherichia coli lac repressor | Q36697418 | ||
| Viral determinants of human immunodeficiency virus type 1 T-cell or macrophage tropism, cytopathogenicity, and CD4 antigen modulation | Q36783052 | ||
| Human immunodeficiency virus type 1 T-cell tropism is determined by events prior to provirus formation | Q36783797 | ||
| Removal of cryptic poxvirus transcription termination signals from the human immunodeficiency virus type 1 envelope gene enhances expression and immunogenicity of a recombinant vaccinia virus. | Q36806386 | ||
| Identification of human immunodeficiency virus envelope gene sequences influencing viral entry into CD4-positive HeLa cells, T-leukemia cells, and macrophages | Q36820658 | ||
| Host range, replicative, and cytopathic properties of human immunodeficiency virus type 1 are determined by very few amino acid changes in tat and gp120 | Q36828914 | ||
| Identification of a determinant within the human immunodeficiency virus 1 surface envelope glycoprotein critical for productive infection of primary monocytes | Q37476959 | ||
| Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. | Q39090316 | ||
| In vitro differentiation of monocytoid THP-1 cells affects their permissiveness for HIV strains: a model system for studying the cellular basis of HIV differential tropism | Q39248709 | ||
| Restricted replication of simian immunodeficiency virus strain 239 in macrophages is determined by env but is not due to restricted entry | Q39268974 | ||
| HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain | Q39313963 | ||
| Distinctive pattern of infection and replication of HIV1 strains in blood-derived macrophages | Q39437630 | ||
| Complementation of murine cells for human immunodeficiency virus envelope/CD4-mediated fusion in human/murine heterokaryons | Q40066675 | ||
| Changing virus-host interactions in the course of HIV-1 infection. | Q40569848 | ||
| Transmission and pathogenesis of human immunodeficiency virus type 1. | Q40693335 | ||
| Cellular and viral determinants that regulate HIV-1 infection in macrophages. | Q40701539 | ||
| Evaluation of viral membrane fusion assays. Comparison of the octadecylrhodamine dequenching assay with the pyrene excimer assay | Q41519776 | ||
| Early replication steps but not cell type-specific signalling of the viral long terminal repeat determine HIV-1 monocytotropism | Q41544138 | ||
| Role of the fusion peptide sequence in initial stages of influenza hemagglutinin-induced cell fusion. | Q41554310 | ||
| Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene | Q41699910 | ||
| Use of a new CD4-positive HeLa cell clone for direct quantitation of infectious human immunodeficiency virus from blood cells of AIDS patients | Q41702349 | ||
| Human genes other than CD4 facilitate HIV-1 infection of murine cells | Q41702917 | ||
| Virus-cell membrane fusion does not predict efficient infection of alveolar macrophages by human immunodeficiency virus type 1 (HIV-1) | Q44452517 | ||
| Lipid-anchored influenza hemagglutinin promotes hemifusion, not complete fusion | Q44633908 | ||
| Simian immunodeficiency virus (SIVmac251) membrane lipid mixing with human CD4+ and CD4- cell lines in vitro does not necessarily result in internalization of the viral core proteins and productive infection | Q45772967 | ||
| Expression of foreign genes in cultured human primary macrophages using recombinant vaccinia virus vectors | Q45778331 | ||
| Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2). | Q48381924 | ||
| The block to HIV-1 envelope glycoprotein-mediated membrane fusion in animal cells expressing human CD4 can be overcome by a human cell component(s) | Q70573568 | ||
| P433 | issue | 19 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | macrophage | Q184204 |
| P304 | page(s) | 9004-9008 | |
| P577 | publication date | 1995-09-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Fusogenic selectivity of the envelope glycoprotein is a major determinant of human immunodeficiency virus type 1 tropism for CD4+ T-cell lines vs. primary macrophages | |
| P478 | volume | 92 |
| Q37049964 | A Designed "Nested" Dimer of Cyanovirin-N Increases Antiviral Activity |
| Q28118386 | A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors |
| Q40928667 | A macrophage fusion assay for rapid screening of cloned HIV-1 Env using dual recombinant vaccinia viruses expressing distinct RNA polymerases |
| Q91900206 | A multivalent HIV-1 fusion inhibitor based on small helical foldamers |
| Q35868457 | A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains. |
| Q28379187 | A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor |
| Q33983104 | Broad-spectrum inhibition of HIV-1 by a monoclonal antibody directed against a gp120-induced epitope of CD4. |
| Q41094625 | CC chemokine receptor 5-mediated signaling and HIV-1 Co-receptor activity share common structural determinants. Critical residues in the third extracellular loop support HIV-1 fusion |
| Q53669311 | CCR5 N-terminal region plays a critical role in HIV-1 inhibition by Toxoplasma gondii-derived cyclophilin-18. |
| Q36831291 | CD4-independent, CCR5-dependent infection of brain capillary endothelial cells by a neurovirulent simian immunodeficiency virus strain |
| Q33782165 | CXCR-4 is expressed by primary macrophages and supports CCR5-independent infection by dual-tropic but not T-tropic isolates of human immunodeficiency virus type 1 |
| Q39577767 | CXCR4 sequences involved in coreceptor determination of human immunodeficiency virus type-1 tropism. Unmasking of activity with M-tropic Env glycoproteins |
| Q35866377 | Cell type-specific fusion cofactors determine human immunodeficiency virus type 1 tropism for T-cell lines versus primary macrophages |
| Q24319950 | ChemR23, a putative chemoattractant receptor, is expressed in monocyte-derived dendritic cells and macrophages and is a coreceptor for SIV and some primary HIV-1 strains |
| Q39265878 | Co-receptors for HIV-1 entry |
| Q28289737 | Cofactors provide the entry keys. HIV-1 |
| Q37334851 | Complementation of diverse HIV-1 Env defects through cooperative subunit interactions: a general property of the functional trimer |
| Q39110633 | Conformational changes in cell surface HIV-1 envelope glycoproteins are triggered by cooperation between cell surface CD4 and co-receptors |
| Q36397946 | Constitutive cell surface association between CD4 and CCR5. |
| Q39167289 | Coreceptor competition for association with CD4 may change the susceptibility of human cells to infection with T-tropic and macrophagetropic isolates of human immunodeficiency virus type 1 |
| Q38356421 | Covalent trimers of the internal N-terminal trimeric coiled-coil of gp41 and antibodies directed against them are potent inhibitors of HIV envelope-mediated cell fusion. |
| Q33648180 | Cyanovirin-N binds to gp120 to interfere with CD4-dependent human immunodeficiency virus type 1 virion binding, fusion, and infectivity but does not affect the CD4 binding site on gp120 or soluble CD4-induced conformational changes in gp120. |
| Q37346420 | Design and evaluation of multi-gene, multi-clade HIV-1 MVA vaccines |
| Q40797427 | Design and properties of N(CCG)-gp41, a chimeric gp41 molecule with nanomolar HIV fusion inhibitory activity |
| Q28245934 | Determinants of HIV-1 coreceptor function on CC chemokine receptor 3. Importance of both extracellular and transmembrane/cytoplasmic regions |
| Q36108620 | Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strains |
| Q30442126 | Dilation of the human immunodeficiency virus-1 envelope glycoprotein fusion pore revealed by the inhibitory action of a synthetic peptide from gp41 |
| Q34341098 | Dissection of human immunodeficiency virus type 1 entry with neutralizing antibodies to gp41 fusion intermediates |
| Q40800273 | Early intermediates in HIV-1 envelope glycoprotein-mediated fusion triggered by CD4 and co-receptor complexes |
| Q29622903 | Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1. |
| Q35122813 | Elevated expression of GM3 in receptor-bearing targets confers resistance to human immunodeficiency virus type 1 fusion. |
| Q35890076 | Enhancement of human immunodeficiency virus type 1 envelope-mediated fusion by a CD4-gp120 complex-specific monoclonal antibody. |
| Q35880289 | Epitope map of human immunodeficiency virus type 1 gp41 derived from 47 monoclonal antibodies produced by immunization with oligomeric envelope protein |
| Q36186612 | Evolution of HIV-1 coreceptor usage through interactions with distinct CCR5 and CXCR4 domains |
| Q37385745 | Exposure to bacterial products renders macrophages highly susceptible to T-tropic HIV-1. |
| Q35693594 | Finding Fusin/CXCR4, the First "2nd Receptor" for HIV Entry |
| Q34717344 | Fluorescent lipid probes in the study of viral membrane fusion |
| Q24678540 | Functional deletion of the CCR5 receptor by intracellular immunization produces cells that are refractory to CCR5-dependent HIV-1 infection and cell fusion |
| Q42831359 | Functional expression of CD4, CXCR4, and CCR5 in glycosphingolipid-deficient mouse melanoma GM95 cells and susceptibility to HIV-1 envelope glycoprotein-triggered membrane fusion |
| Q39160311 | Fusion of monocytes and macrophages with HIV-1 correlates with biochemical properties of CXCR4 and CCR5. |
| Q33807605 | Glycosphingolipids promote entry of a broad range of human immunodeficiency virus type 1 isolates into cell lines expressing CD4, CXCR4, and/or CCR5. |
| Q57788672 | HIV-1 inhibitory properties of eCD4-Igmim2 determined using an Env-mediated membrane fusion assay |
| Q34124118 | Human beta-defensins suppress human immunodeficiency virus infection: potential role in mucosal protection. |
| Q40754415 | Human immunodeficiency virus envelope-dependent cell-cell fusion: a quantitative fluorescence cytometric assay |
| Q39580343 | Human immunodeficiency virus type 1 T-lymphotropic strains enter macrophages via a CD4- and CXCR4-mediated pathway: replication is restricted at a postentry level |
| Q35868872 | Human immunodeficiency virus type 1 membrane fusion mediated by a laboratory-adapted strain and a primary isolate analyzed by resonance energy transfer. |
| Q33782530 | Identification of determinants on a dualtropic human immunodeficiency virus type 1 envelope glycoprotein that confer usage of CXCR4 |
| Q33835295 | Immunogenicity and protective efficacy of oligomeric human immunodeficiency virus type 1 gp140. |
| Q33843554 | Immunoglobulin G3 from polyclonal human immunodeficiency virus (HIV) immune globulin is more potent than other subclasses in neutralizing HIV type 1. |
| Q36496923 | Increased efficacy of HIV-1 neutralization by antibodies at low CCR5 surface concentration. |
| Q34545923 | Induction of neutralizing antibodies to Hendra and Nipah glycoproteins using a Venezuelan equine encephalitis virus in vivo expression system |
| Q22254101 | Interactions of CCR5 and CXCR4 with CD4 and gp120 in human blood monocyte-derived dendritic cells |
| Q39106404 | Maturation of the viral core enhances the fusion of HIV-1 particles with primary human T cells and monocyte-derived macrophages |
| Q27472931 | Membrane fusion tropism and heterotypic functional activities of the Nipah virus and Hendra virus envelope glycoproteins |
| Q33804363 | Multiple antiviral activities of cyanovirin-N: blocking of human immunodeficiency virus type 1 gp120 interaction with CD4 and coreceptor and inhibition of diverse enveloped viruses |
| Q39355095 | Multiple extracellular domains of CCR-5 contribute to human immunodeficiency virus type 1 entry and fusion. |
| Q33817249 | Mutagenesis of CXCR4 identifies important domains for human immunodeficiency virus type 1 X4 isolate envelope-mediated membrane fusion and virus entry and reveals cryptic coreceptor activity for R5 isolates |
| Q33804016 | N-linked glycosylation of CXCR4 masks coreceptor function for CCR5-dependent human immunodeficiency virus type 1 isolates |
| Q35143155 | Necroptosis takes place in human immunodeficiency virus type-1 (HIV-1)-infected CD4+ T lymphocytes. |
| Q37114703 | New carbohydrate specificity and HIV-1 fusion blocking activity of the cyanobacterial protein MVL: NMR, ITC and sedimentation equilibrium studies |
| Q33782930 | Patterns of CCR5, CXCR4, and CCR3 usage by envelope glycoproteins from human immunodeficiency virus type 1 primary isolates. |
| Q39406629 | Physiological coreceptor use by dual-tropic HIV-1: one plus one equals one. |
| Q95824427 | Pillars article: HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science. 1996. 272: 872-877 |
| Q33850605 | Polyvalent envelope glycoprotein vaccine elicits a broader neutralizing antibody response but is unable to provide sterilizing protection against heterologous Simian/human immunodeficiency virus infection in pigtailed macaques |
| Q36954218 | Promoting trimerization of soluble human immunodeficiency virus type 1 (HIV-1) Env through the use of HIV-1/simian immunodeficiency virus chimeras |
| Q40423310 | Receptor binding, fusion inhibition, and induction of cross-reactive neutralizing antibodies by a soluble G glycoprotein of Hendra virus |
| Q33996980 | Recombinant vaccinia viruses. Design, generation, and isolation |
| Q39413074 | Regions in beta-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity |
| Q37185404 | Resistance to human immunodeficiency virus type 1 (HIV-1) generated by lentivirus vector-mediated delivery of the CCR5{Delta}32 gene despite detectable expression of the HIV-1 co-receptors |
| Q33648601 | Role of CXCR4 in cell-cell fusion and infection of monocyte-derived macrophages by primary human immunodeficiency virus type 1 (HIV-1) strains: two distinct mechanisms of HIV-1 dual tropism. |
| Q30865013 | Role of cholesterol in human immunodeficiency virus type 1 envelope protein-mediated fusion with host cells |
| Q24324020 | STRL33, A novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic HIV-1 |
| Q33794954 | Sequential CD4-coreceptor interactions in human immunodeficiency virus type 1 Env function: soluble CD4 activates Env for coreceptor-dependent fusion and reveals blocking activities of antibodies against cryptic conserved epitopes on gp120. |
| Q40280740 | Sphingolipids, cholesterol, and HIV-1: a paradigm in viral fusion |
| Q90240356 | Structural and functional analyses reveal promiscuous and species specific use of ephrin receptors by Cedar virus |
| Q45094657 | Structural determinants of the anti-HIV activity of a CCR5 antagonist derived from Toxoplasma gondii. |
| Q45742209 | Substitutions in a homologous region of extracellular loop 2 of CXCR4 and CCR5 alter coreceptor activities for HIV-1 membrane fusion and virus entry |
| Q31035863 | Synthetic combinatorial libraries as an alternative strategy for the development of novel treatments for infectious diseases |
| Q24531215 | The B-oligomer of pertussis toxin inhibits human immunodeficiency virus type 1 replication at multiple stages |
| Q28188544 | The HIV Env-mediated fusion reaction |
| Q28282895 | The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates |
| Q35741691 | The tyrosine kinase inhibitor genistein blocks HIV-1 infection in primary human macrophages |
| Q35890885 | Two distinct CCR5 domains can mediate coreceptor usage by human immunodeficiency virus type 1. |
| Q39137268 | Use of helper-free replication-defective simian immunodeficiency virus-based vectors to study macrophage and T tropism: evidence for distinct levels of restriction in primary macrophages and a T-cell line |
| Q39413069 | Utilization of chemokine receptors, orphan receptors, and herpesvirus-encoded receptors by diverse human and simian immunodeficiency viruses |
Search more.